Serum lipids and endometrial cancer risk: Results from the HUNT‐II study
Obesity is a major risk factor for endometrial cancer. Still, the association of obesity‐related metabolic factors, such as serum lipids and lipoprotein levels, is unclear. We prospectively examined the association of serum levels of triglycerides, total cholesterol, low‐density lipoprotein choleste...
Saved in:
Published in | International journal of cancer Vol. 124; no. 12; pp. 2938 - 2941 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
15.06.2009
Wiley-Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Obesity is a major risk factor for endometrial cancer. Still, the association of obesity‐related metabolic factors, such as serum lipids and lipoprotein levels, is unclear. We prospectively examined the association of serum levels of triglycerides, total cholesterol, low‐density lipoprotein cholesterol, non–high‐density lipoprotein (non‐HDL), and HDL cholesterol with endometrial cancer risk among 31,473 women. During 9 years of follow‐up, 100 cases of endometrial cancer were identified by linkage to the Cancer Registry of Norway. There was a positive association of serum triglyceride levels with endometrial cancer risk. Comparing the highest to the lowest quartile of triglycerides, the age‐adjusted hazard ratio was 2.34 (95% CI: 1.04–5.28), and further adjustment for body mass index attenuated the association (hazard ratio 1.79, 95% CI: 0.79–4.05). For total serum cholesterol, low‐density lipoprotein cholesterol and HDL cholesterol there were no associations with endometrial cancer risk, either without or after adjustment for body mass index. Serum triglyceride levels were positively associated with the risk of endometrial cancer, and some of the association seems to be attributable to obesity. Apart from higher estrogen levels produced in adipose tissue, mechanisms more specifically related to triglycerides may also be involved in endometrial cancer. Further prospective studies on this subject are needed to better understand the association of blood lipids with endometrial cancer risk. © 2009 UICC |
---|---|
AbstractList | Obesity is a major risk factor for endometrial cancer. Still, the association of obesity-related metabolic factors, such as serum lipids and lipoprotein levels, is unclear. We prospectively examined the association of serum levels of triglycerides, total cholesterol, low-density lipoprotein cholesterol, non-high-density lipoprotein (non-HDL), and HDL cholesterol with endometrial cancer risk among 31,473 women. During 9 years of follow-up, 100 cases of endometrial cancer were identified by linkage to the Cancer Registry of Norway. There was a positive association of serum triglyceride levels with endometrial cancer risk. Comparing the highest to the lowest quartile of triglycerides, the age-adjusted hazard ratio was 2.34 (95% CI: 1.04-5.28), and further adjustment for body mass index attenuated the association (hazard ratio 1.79, 95% CI: 0.79-4.05). For total serum cholesterol, low-density lipoprotein cholesterol and HDL cholesterol there were no associations with endometrial cancer risk, either without or after adjustment for body mass index. Serum triglyceride levels were positively associated with the risk of endometrial cancer, and some of the association seems to be attributable to obesity. Apart from higher estrogen levels produced in adipose tissue, mechanisms more specifically related to triglycerides may also be involved in endometrial cancer. Further prospective studies on this subject are needed to better understand the association of blood lipids with endometrial cancer risk. Abstract Obesity is a major risk factor for endometrial cancer. Still, the association of obesity‐related metabolic factors, such as serum lipids and lipoprotein levels, is unclear. We prospectively examined the association of serum levels of triglycerides, total cholesterol, low‐density lipoprotein cholesterol, non–high‐density lipoprotein (non‐HDL), and HDL cholesterol with endometrial cancer risk among 31,473 women. During 9 years of follow‐up, 100 cases of endometrial cancer were identified by linkage to the Cancer Registry of Norway. There was a positive association of serum triglyceride levels with endometrial cancer risk. Comparing the highest to the lowest quartile of triglycerides, the age‐adjusted hazard ratio was 2.34 (95% CI: 1.04–5.28), and further adjustment for body mass index attenuated the association (hazard ratio 1.79, 95% CI: 0.79–4.05). For total serum cholesterol, low‐density lipoprotein cholesterol and HDL cholesterol there were no associations with endometrial cancer risk, either without or after adjustment for body mass index. Serum triglyceride levels were positively associated with the risk of endometrial cancer, and some of the association seems to be attributable to obesity. Apart from higher estrogen levels produced in adipose tissue, mechanisms more specifically related to triglycerides may also be involved in endometrial cancer. Further prospective studies on this subject are needed to better understand the association of blood lipids with endometrial cancer risk. © 2009 UICC Obesity is a major risk factor for endometrial cancer. Still, the association of obesity‐related metabolic factors, such as serum lipids and lipoprotein levels, is unclear. We prospectively examined the association of serum levels of triglycerides, total cholesterol, low‐density lipoprotein cholesterol, non–high‐density lipoprotein (non‐HDL), and HDL cholesterol with endometrial cancer risk among 31,473 women. During 9 years of follow‐up, 100 cases of endometrial cancer were identified by linkage to the Cancer Registry of Norway. There was a positive association of serum triglyceride levels with endometrial cancer risk. Comparing the highest to the lowest quartile of triglycerides, the age‐adjusted hazard ratio was 2.34 (95% CI: 1.04–5.28), and further adjustment for body mass index attenuated the association (hazard ratio 1.79, 95% CI: 0.79–4.05). For total serum cholesterol, low‐density lipoprotein cholesterol and HDL cholesterol there were no associations with endometrial cancer risk, either without or after adjustment for body mass index. Serum triglyceride levels were positively associated with the risk of endometrial cancer, and some of the association seems to be attributable to obesity. Apart from higher estrogen levels produced in adipose tissue, mechanisms more specifically related to triglycerides may also be involved in endometrial cancer. Further prospective studies on this subject are needed to better understand the association of blood lipids with endometrial cancer risk. © 2009 UICC |
Author | Eskild, Anne Ellstrøm‐Engh, Marie Lindemann, Kristina Vatten, Lars J. |
Author_xml | – sequence: 1 givenname: Kristina surname: Lindemann fullname: Lindemann, Kristina email: kristina.lindemann@ahus.no – sequence: 2 givenname: Lars J. surname: Vatten fullname: Vatten, Lars J. – sequence: 3 givenname: Marie surname: Ellstrøm‐Engh fullname: Ellstrøm‐Engh, Marie – sequence: 4 givenname: Anne surname: Eskild fullname: Eskild, Anne |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21370929$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19267407$$D View this record in MEDLINE/PubMed https://gup.ub.gu.se/publication/147434$$DView record from Swedish Publication Index |
BookMark | eNqF0c1OFTEUB_DGYOSCLnwB040kLAb6Ne2MO3ODcgnRRGHddNozWJwv22nI3fkIPKNPQmFucGVcNTn95ZyT8z9Ae8M4AEJvKTmhhLBTf2tPmGBV-QKtKKlVQRgt99Aq_5FCUS730UGMt4RQWhLxCu3TmkkliFqhi-8QUo87P3kXsRkchsGNPczBmw5bM1gIOPj48wP-BjF1c8RtGHs8_wB8fv3l6s_v-80Gxzm57Wv0sjVdhDe79xBdfzq7Wp8Xl18_b9YfLwtbMl4WktZglagYM6KUjtuqLKXkjWulVVVjGuYcCCFaQ5VsakZaKptK1jXljkvZ8ENULH3jHUyp0VPwvQlbPRqvb9Kkc-km6QiaCiW4yP5o8VMYfyWIs-59tNB1ZoAxRS3zhSqu6v9CRiSnqiIZHi_QhjHGAO3zDpTox0R0TkQ_JZLtu13T1PTg_spdBBm83wETrenakG_u47NjlCtSs8ftThd35zvY_nui3lysl9EPOGqjEA |
CODEN | IJCNAW |
CitedBy_id | crossref_primary_10_1016_j_ygyno_2024_02_017 crossref_primary_10_1002_ijc_33206 crossref_primary_10_1017_S1368980011001066 crossref_primary_10_1111_eci_12185 crossref_primary_10_1007_s12020_013_9973_3 crossref_primary_10_1155_2015_593658 crossref_primary_10_1158_1055_9965_EPI_10_0832 crossref_primary_10_1002_cncr_25455 crossref_primary_10_4178_epih_e2023049 crossref_primary_10_1186_s12885_023_11053_4 crossref_primary_10_18632_aging_103247 crossref_primary_10_1186_s12885_024_12434_z crossref_primary_10_3389_fonc_2023_1052760 crossref_primary_10_1093_jjco_hyt125 crossref_primary_10_1155_2013_823849 crossref_primary_10_1097_IGC_0000000000000819 crossref_primary_10_1186_s41231_022_00129_1 crossref_primary_10_1080_01635581_2023_2294521 crossref_primary_10_1515_HMBCI_2010_027 crossref_primary_10_1186_s12958_022_01006_0 crossref_primary_10_3390_cancers14194912 crossref_primary_10_1158_1055_9965_EPI_11_0715 crossref_primary_10_1186_s12916_022_02322_3 crossref_primary_10_1530_ERC_17_0449 crossref_primary_10_1093_annonc_mdq464 crossref_primary_10_4236_ijcm_2015_612129 crossref_primary_10_1186_s12967_022_03851_4 crossref_primary_10_1371_journal_pone_0104630 crossref_primary_10_1007_s13277_016_4799_2 crossref_primary_10_1093_hropen_hoae033 crossref_primary_10_3109_09513590_2015_1058355 crossref_primary_10_1016_j_biopha_2023_114526 crossref_primary_10_1002_cam4_5463 crossref_primary_10_1186_s12916_022_02246_y crossref_primary_10_2147_IJGM_S352934 crossref_primary_10_3390_cancers12051292 crossref_primary_10_1093_annonc_mdv142 crossref_primary_10_1016_j_biochi_2014_03_010 crossref_primary_10_56766_ntms_1297303 crossref_primary_10_7759_cureus_62099 crossref_primary_10_1016_j_ygyno_2009_12_029 crossref_primary_10_1080_01443615_2020_1819210 crossref_primary_10_1186_1471_2288_12_21 crossref_primary_10_1007_s10552_017_0991_y crossref_primary_10_4236_jdm_2022_122011 |
Cites_doi | 10.1016/S0022-2275(20)42625-2 10.1101/gad.8.10.1224 10.1016/0021-9681(80)90026-0 10.1186/1476-4598-5-13 10.1159/000063081 10.1677/ERC-07-0132 10.1210/jc.80.7.2057 10.1093/clinchem/18.6.499 10.1158/1078-0432.CCR-05-1833 10.1016/S0002-9343(99)80058-8 10.1016/S0026-0495(97)90159-1 10.1056/NEJM199908053410604 10.1126/science.294.5548.1866 10.33549/physiolres.930848 10.1007/s00059-005-2708-3 10.1056/NEJM198711123172001 10.1001/jama.1981.03310280023021 10.1046/j.1365-2796.2002.01025.x 10.1002/1097-0215(200002)9999:9999<::AID-IJC1053>3.0.CO;2-T 10.1007/BF00052142 10.1155/2008/102737 10.1210/jc.2003-031716 10.1038/sj.bjc.6604313 10.1046/j.1440-1711.2000.00921.x 10.1038/sj.ijo.0802806 |
ContentType | Journal Article |
Copyright | Copyright © 2009 UICC 2009 INIST-CNRS Copyright 2008 UICC. |
Copyright_xml | – notice: Copyright © 2009 UICC – notice: 2009 INIST-CNRS – notice: Copyright 2008 UICC. |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7U1 7U2 C1K 7X8 ADTPV AOWAS F1U |
DOI | 10.1002/ijc.24285 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Risk Abstracts Safety Science and Risk Environmental Sciences and Pollution Management MEDLINE - Academic SwePub SwePub Articles SWEPUB Göteborgs universitet |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Risk Abstracts Safety Science and Risk Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic Risk Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-0215 |
EndPage | 2941 |
ExternalDocumentID | oai_gup_ub_gu_se_147434 10_1002_ijc_24285 19267407 21370929 IJC24285 |
Genre | article Randomized Controlled Trial Multicenter Study Journal Article |
GeographicLocations | Norway |
GeographicLocations_xml | – name: Norway |
GroupedDBID | --- -~X .3N .55 .GA .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EX3 F00 F01 F04 F5P FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 RYL SUPJJ TEORI UB1 UDS V2E V8K V9Y W2D W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WOW WQJ WRC WUP WVDHM WWO WXI WXSBR X7M XG1 XPP XV2 ZZTAW ~IA ~WT .GJ 3O- 8WZ A6W AAJUZ AAPBV AAUGY AAVGM ABCVL ABEFU ABEML ABHUG ABWRO ACBWZ ACSCC ACSMX ACXME ADAWD ADDAD AFVGU AGJLS AHEFC AI. ASPBG AVWKF AZFZN BDRZF EMOBN FEDTE GLUZI IQODW M6P PALCI SAMSI VH1 Y6R ZGI ZXP CGR CUY CVF ECM EIF NPM AAYXX CITATION 7U1 7U2 C1K 7X8 ADTPV AOWAS F1U HVGLF |
ID | FETCH-LOGICAL-c5235-619ec74822a456d3c855663bdf6c78bab2dde444fa176b920f16b869913d366b3 |
IEDL.DBID | DR2 |
ISSN | 0020-7136 1097-0215 |
IngestDate | Sat Aug 24 00:42:59 EDT 2024 Sat Aug 17 04:04:53 EDT 2024 Fri Aug 16 08:51:43 EDT 2024 Fri Aug 23 01:23:02 EDT 2024 Sat Sep 28 07:57:02 EDT 2024 Sun Oct 22 16:07:28 EDT 2023 Sat Aug 24 00:55:12 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Obesity Endometrium cancer Nutrition disorder Lipids Malignant tumor Epidemiology Blood blood lipids Female genital diseases Cancerology Risk factor Uterine diseases endometrial cancer Serum Nutritional status Cancer |
Language | English |
License | CC BY 4.0 Copyright 2008 UICC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5235-619ec74822a456d3c855663bdf6c78bab2dde444fa176b920f16b869913d366b3 |
Notes | Fax: ++47‐67‐92‐8845. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-News-2 ObjectType-Feature-3 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.24285 |
PMID | 19267407 |
PQID | 20631780 |
PQPubID | 23462 |
PageCount | 4 |
ParticipantIDs | swepub_primary_oai_gup_ub_gu_se_147434 proquest_miscellaneous_67138379 proquest_miscellaneous_20631780 crossref_primary_10_1002_ijc_24285 pubmed_primary_19267407 pascalfrancis_primary_21370929 wiley_primary_10_1002_ijc_24285_IJC24285 |
PublicationCentury | 2000 |
PublicationDate | 15 June 2009 |
PublicationDateYYYYMMDD | 2009-06-15 |
PublicationDate_xml | – month: 06 year: 2009 text: 15 June 2009 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | Hoboken |
PublicationPlace_xml | – name: Hoboken – name: Hoboken, NJ – name: United States |
PublicationTitle | International journal of cancer |
PublicationTitleAlternate | Int J Cancer |
PublicationYear | 2009 |
Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley-Blackwell |
Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley-Blackwell |
References | 1990; 31 1991; 2 2002; 252 1981; 245 2006; 12 2006; 55 2004; 28 1997; 46 2004; 89 2002; 11 1995; 98 1999; 341 2006; 5 2008; 98 1993; 149 2008; 2008 2007; 14 1982; 68 1994; 8 2001; 294 1995; 80 2000; 78 2002; 46 1980; 33 1997; 57 1987; 317 2001; 19 2005; 30 1994; 3 1972; 18 e_1_2_5_26_2 e_1_2_5_27_2 e_1_2_5_24_2 e_1_2_5_25_2 e_1_2_5_22_2 e_1_2_5_23_2 Bergstrom A (e_1_2_5_2_2) 2001; 19 e_1_2_5_21_2 Shumak SL (e_1_2_5_16_2) 1993; 149 e_1_2_5_28_2 e_1_2_5_29_2 Swanson CA (e_1_2_5_12_2) 1994; 3 e_1_2_5_14_2 Wallace RB (e_1_2_5_19_2) 1982; 68 e_1_2_5_13_2 Kaaks R (e_1_2_5_4_2) 2002; 11 e_1_2_5_8_2 e_1_2_5_15_2 e_1_2_5_7_2 e_1_2_5_10_2 e_1_2_5_6_2 e_1_2_5_5_2 e_1_2_5_31_2 e_1_2_5_11_2 e_1_2_5_3_2 e_1_2_5_18_2 Goodman MT (e_1_2_5_20_2) 1997; 57 e_1_2_5_17_2 Housa D (e_1_2_5_9_2) 2006; 55 e_1_2_5_30_2 |
References_xml | – volume: 14 start-page: 755 year: 2007 end-page: 67 article-title: Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) publication-title: Endocr Relat Cancer – volume: 80 start-page: 2057 year: 1995 end-page: 62 article-title: Effects of diet and metformin administration on sex hormone‐binding globulin, androgens, and insulin in hirsute and obese women publication-title: J Clin Endocrinol Metab – volume: 57 start-page: 5077 year: 1997 end-page: 85 article-title: Diet, body size, physical activity, and the risk of endometrial cancer publication-title: Cancer Res – volume: 3 start-page: 575 year: 1994 end-page: 81 article-title: Endometrial cancer risk in relation to serum lipids and lipoprotein levels publication-title: Cancer Epidemiol Biomarkers Prev – volume: 31 start-page: 1149 year: 1990 end-page: 72 article-title: Dietary influences on serum lipids and lipoproteins publication-title: J Lipid Res – volume: 252 start-page: 164 year: 2002 end-page: 72 article-title: Microalbuminuria, cardiovascular disease and risk factors in a nondiabetic/nonhypertensive population. The Nord‐Trondelag. Health Study (HUNT, 1995–97), Norway publication-title: J Intern Med – volume: 78 start-page: 436 year: 2000 end-page: 41 article-title: Peroxisome proliferator‐activated receptors in tumorigenesis: targets of tumour promotion and treatment publication-title: Immunol Cell Biol – volume: 12 start-page: 4200 year: 2006 end-page: 8 article-title: Peroxisome proliferator‐activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma publication-title: Clin Cancer Res – volume: 149 start-page: 843 year: 1993 end-page: 4 article-title: Intraindividual variation in lipid and lipoprotein levels publication-title: CMAJ – volume: 89 start-page: 1160 year: 2004 end-page: 3 article-title: Circulating adiponectin and endometrial cancer risk publication-title: J Clin Endocrinol Metab – volume: 11 start-page: 1531 year: 2002 end-page: 43 article-title: Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review publication-title: Cancer Epidemiol Biomarkers Prev – volume: 8 start-page: 1224 year: 1994 end-page: 34 article-title: mPPAR gamma 2: tissue‐specific regulator of an adipocyte enhancer publication-title: Genes Dev – volume: 19 start-page: 421 year: 2001 end-page: 30 article-title: Overweight as an avoidable cause of cancer in Europe publication-title: Int J Cancer – volume: 2008 start-page: 102737 year: 2008 article-title: The role of PPARs in cancer publication-title: PPAR Res – volume: 55 start-page: 233 year: 2006 end-page: 44 article-title: Adipocytokines and cancer publication-title: Physiol Res – volume: 28 start-page: S75 issue: Suppl 3 year: 2004 end-page: S80 article-title: Hormones regulating lipid metabolism and plasma lipids in childhood obesity publication-title: Int J Obes Relat Metab Disord – volume: 46 start-page: 147 year: 2002 end-page: 51 article-title: Leptin and body mass index in relation to endometrial cancer risk publication-title: Ann Nutr Metab – volume: 294 start-page: 1866 year: 2001 end-page: 70 article-title: Nuclear receptors and lipid physiology: opening the X‐files publication-title: Science – volume: 317 start-page: 1237 year: 1987 end-page: 45 article-title: Helsinki Heart Study: primary‐prevention trial with gemfibrozil in middle‐aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease publication-title: N Engl J Med – volume: 33 start-page: 311 year: 1980 end-page: 32 article-title: The relationship of serum cholesterol to the incidence of cancer in Evans County. Georgia publication-title: J Chronic Dis – volume: 98 start-page: 40S year: 1995 end-page: 47S article-title: Endogenous sex hormones: impact on lipids, lipoproteins, and insulin publication-title: Am J Med – volume: 5 start-page: 13 year: 2006 article-title: In vitro and in vivo effects of the PPAR‐alpha agonists fenofibrate and retinoic acid in endometrial cancer publication-title: Mol Cancer – volume: 98 start-page: 1582 year: 2008 end-page: 5 article-title: Body mass, diabetes and smoking, and endometrial cancer risk: a follow‐up study publication-title: Br J Cancer – volume: 2 start-page: 253 year: 1991 end-page: 61 article-title: Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies publication-title: Cancer Causes Control – volume: 30 start-page: 368 year: 2005 end-page: 74 article-title: Lipids and lipoproteins in women publication-title: Herz – volume: 46 start-page: 5 year: 1997 end-page: 9 article-title: Determinants of sex hormone‐binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio‐Menopause‐Health Group publication-title: Metabolism – volume: 18 start-page: 499 year: 1972 end-page: 502 article-title: Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge publication-title: Clin Chem – volume: 245 start-page: 247 year: 1981 end-page: 52 article-title: Cancer incidence by levels of cholesterol publication-title: JAMA – volume: 68 start-page: 915 year: 1982 end-page: 8 article-title: Cancer incidence in humans: relationship to plasma lipids and relative weight publication-title: J Natl Cancer Inst – volume: 341 start-page: 410 year: 1999 end-page: 8 article-title: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high‐density lipoprotein cholesterol. Veterans Affairs High‐Density Lipoprotein Cholesterol Intervention Trial Study Group publication-title: N Engl J Med – ident: e_1_2_5_10_2 doi: 10.1016/S0022-2275(20)42625-2 – volume: 57 start-page: 5077 year: 1997 ident: e_1_2_5_20_2 article-title: Diet, body size, physical activity, and the risk of endometrial cancer publication-title: Cancer Res contributor: fullname: Goodman MT – ident: e_1_2_5_25_2 doi: 10.1101/gad.8.10.1224 – volume: 3 start-page: 575 year: 1994 ident: e_1_2_5_12_2 article-title: Endometrial cancer risk in relation to serum lipids and lipoprotein levels publication-title: Cancer Epidemiol Biomarkers Prev contributor: fullname: Swanson CA – ident: e_1_2_5_18_2 doi: 10.1016/0021-9681(80)90026-0 – ident: e_1_2_5_30_2 doi: 10.1186/1476-4598-5-13 – ident: e_1_2_5_7_2 doi: 10.1159/000063081 – ident: e_1_2_5_11_2 doi: 10.1677/ERC-07-0132 – ident: e_1_2_5_5_2 doi: 10.1210/jc.80.7.2057 – ident: e_1_2_5_15_2 doi: 10.1093/clinchem/18.6.499 – volume: 68 start-page: 915 year: 1982 ident: e_1_2_5_19_2 article-title: Cancer incidence in humans: relationship to plasma lipids and relative weight publication-title: J Natl Cancer Inst contributor: fullname: Wallace RB – ident: e_1_2_5_31_2 doi: 10.1158/1078-0432.CCR-05-1833 – ident: e_1_2_5_22_2 doi: 10.1016/S0002-9343(99)80058-8 – ident: e_1_2_5_6_2 doi: 10.1016/S0026-0495(97)90159-1 – ident: e_1_2_5_29_2 doi: 10.1056/NEJM199908053410604 – volume: 11 start-page: 1531 year: 2002 ident: e_1_2_5_4_2 article-title: Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review publication-title: Cancer Epidemiol Biomarkers Prev contributor: fullname: Kaaks R – ident: e_1_2_5_24_2 doi: 10.1126/science.294.5548.1866 – volume: 55 start-page: 233 year: 2006 ident: e_1_2_5_9_2 article-title: Adipocytokines and cancer publication-title: Physiol Res doi: 10.33549/physiolres.930848 contributor: fullname: Housa D – ident: e_1_2_5_21_2 doi: 10.1007/s00059-005-2708-3 – ident: e_1_2_5_28_2 doi: 10.1056/NEJM198711123172001 – ident: e_1_2_5_17_2 doi: 10.1001/jama.1981.03310280023021 – ident: e_1_2_5_14_2 doi: 10.1046/j.1365-2796.2002.01025.x – volume: 19 start-page: 421 year: 2001 ident: e_1_2_5_2_2 article-title: Overweight as an avoidable cause of cancer in Europe publication-title: Int J Cancer doi: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1053>3.0.CO;2-T contributor: fullname: Bergstrom A – ident: e_1_2_5_13_2 doi: 10.1007/BF00052142 – volume: 149 start-page: 843 year: 1993 ident: e_1_2_5_16_2 article-title: Intraindividual variation in lipid and lipoprotein levels publication-title: CMAJ contributor: fullname: Shumak SL – ident: e_1_2_5_27_2 doi: 10.1155/2008/102737 – ident: e_1_2_5_8_2 doi: 10.1210/jc.2003-031716 – ident: e_1_2_5_3_2 doi: 10.1038/sj.bjc.6604313 – ident: e_1_2_5_26_2 doi: 10.1046/j.1440-1711.2000.00921.x – ident: e_1_2_5_23_2 doi: 10.1038/sj.ijo.0802806 |
SSID | ssj0011504 |
Score | 2.239683 |
Snippet | Obesity is a major risk factor for endometrial cancer. Still, the association of obesity‐related metabolic factors, such as serum lipids and lipoprotein... Obesity is a major risk factor for endometrial cancer. Still, the association of obesity-related metabolic factors, such as serum lipids and lipoprotein... Abstract Obesity is a major risk factor for endometrial cancer. Still, the association of obesity‐related metabolic factors, such as serum lipids and... |
SourceID | swepub proquest crossref pubmed pascalfrancis wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 2938 |
SubjectTerms | Biological and medical sciences blood blood lipids Cholesterol Cholesterol - blood Cholesterol, HDL - blood Cholesterol, LDL - blood endometrial cancer Endometrial Neoplasms Endometrial Neoplasms - blood Endometrial Neoplasms - epidemiology epidemiology Female Female genital diseases Follow-Up Studies Gynecology. Andrology. Obstetrics HDL Humans LDL Lipids Lipids - blood Medical sciences Middle Aged Norway Norway - epidemiology obesity Obstetrics, Gynecology and Reproductive Medicine Prospective Studies Questionnaires Reproduktionsmedicin och gynekologi Risk Assessment Risk Factors Surveys and Questionnaires Triglycerides Triglycerides - blood Tumors |
Title | Serum lipids and endometrial cancer risk: Results from the HUNT‐II study |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.24285 https://www.ncbi.nlm.nih.gov/pubmed/19267407 https://search.proquest.com/docview/20631780 https://search.proquest.com/docview/67138379 https://gup.ub.gu.se/publication/147434 |
Volume | 124 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD6UPogg1nqN2jqIiC_ZJplLJvokxbK70D6ULvRBGOaWsrbNLs3mxSd_gr_RX-KZZJOyYkF8C8mZkJlzme9k5nwD8A4jnDVc2tj4tIyZZzLWPDFxlnuqHTW0EKE4-fhEjGdses7Pt-BTXwvT8UMMP9yCZ7TxOji4NvXBLWno_Jsd4fwiQ4F5INILgOh0oI4KQGfNwJzEmIiJnlUoyQ6Glhtz0YOlrnFYyu48i78BzoFNdBPItjPR0Q587fvQbUC5HDUrM7Lf_6B3_M9OPoKHa4RKPncmtQtbvnoM947Xa_BPYIrhpbkmV_Pl3NVEV474yi2ufXv-B7HBim5I2LH-kZz6urla1STUsBBEmmQ8Ozn79ePnZEJaWtunMDv6cnY4jtcnMsQWE1aOeWbhbc4QVGgEXo5ayREOUuNKYXNptMkwWjLGSp3mwhRZUqbCSIEYlDoqhKHPYLtaVP4FEOls4i0vecFK5rjU3gnDObakzlCmI3jb60YtO-IN1VEsZwpHRbWjEsH-htYGySyleYLIL4I3vRoV-k1YDNGVXzS1yhCbpblM7pYQaDaYvuM7nnf6v_2OIhM5ZsIRvO8MYngSyLovmqXCWxeNqj1mVgjRWAQfWi3f3RM1mR62Fy__XfQV3O_WtkSc8tewvbpp_B5CpJXZb33hN4dADQo |
link.rule.ids | 230,315,786,790,891,1382,27955,27956,46327,46751 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFH4qRQIkxE4xSztCCHFxansW24gLKlRJaHKoEqkXNJrNVWjrRHV84cRP4DfyS3hjJ66CqIS4WeMZy2_eMt-b5RuANxjhjOaZCbWLi5A5loWKRzpMUkeVpZrmwh9OHo1Ff8qGJ_xkCz6sz8K0_BDdhJv3jCZeewf3E9L7V6yhs2-mhwNMxm_ATXR37t3y03FHHuWhzoqDOQoxFRNrXqEo2e-aboxGdxeqwo4p2hst_gY5Oz7RTSjbjEWH9-HrWop2C8pZr17qnvn-B8Hj_4r5AO6tQCr52FrVQ9hy5SO4NVotwz-GIUaY-oKczxYzWxFVWuJKO79wzRUgxHhDuiR-0_p7cuyq-nxZEX-MhSDYJP3pePLrx8_BgDTMtk9gevh5ctAPV5cyhAZzVo6pZu5MyhBXKMRelpqMIyKk2hbCpJlWOsGAyRgrVJwKnSdREQudCYSh1FIhNH0K2-W8dM-AZNZEzvCC56xglmfKWaE5x5bUaspUAK_XypGLlntDtizLicRekU2vBLC7obauZhLTNELwF8DeWo8SXcevh6jSzetKJgjP4jSLrq8h0G4wg8dv7LQGcPUfeSJSTIYDeNtaRPfG83Wf1guJRae1rBwmV4jSWADvGjVfL4kcDA-ah-f_XnUPbvcnoyN5NBh_eQF32qUuEcb8JWwvL2v3ChHTUu82jvEbUSURKg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3batRAGP6pFYog9VgbD-0gIt5km2QOSfRKWpfd1S5SutALYZhTymqbDc3mxisfwWf0SfyTbFJWLIh3IZkJmfkP832ZmW8AXmGGM5onxtcuzHzmWOIrHmg_ih1Vlmqainpz8vFUjGZscsbPNuBdtxem1Yfof7jVkdHk6zrAC5sdXIuGzr-aAY4vCb8Ft5mgUc28jk567aga6awkmAMfmZjoZIWC6KCvujYY3S1Uif2StQda_A1x9nKi60i2GYqG9-BL14h2Bcq3QbXUA_P9D33H_2zlfdheQVTyvvWpB7Dh8oewdbyahH8EE8wv1SW5mBdzWxKVW-Jyu7h0zQEgxNRudEXqJetvyYkrq4tlSepNLAShJhnNpqe_fvwcj0mja_sYZsMPp4cjf3Ukg2-QsXIkmqkzMUNUoRB5WWoSjniQapsJEyda6QjTJWMsU2EsdBoFWSh0IhCEUkuF0HQHNvNF7naBJNYEzvCMpyxjlifKWaE5x5rUasqUBy8728iiVd6QrcZyJLFXZNMrHuytWa0vGYU0DhD6ebDfmVFi4NSzISp3i6qUEYKzME6Cm0sIdBvk7_iOJ639r78jjUSMVNiD161D9E9qte7zqpB467ySpUNqhRiNefCmsfLNLZHjyWFz8fTfi-7D1uejofw0nn58BnfaeS7hh_w5bC6vKvcC4dJS7zVh8RsZSg_Z |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+lipids+and+endometrial+cancer+risk%3A+Results+from+the+HUNT%E2%80%90II+study&rft.jtitle=International+journal+of+cancer&rft.au=Lindemann%2C+Kristina&rft.au=Vatten%2C+Lars+J.&rft.au=Ellstr%C3%B8m%E2%80%90Engh%2C+Marie&rft.au=Eskild%2C+Anne&rft.date=2009-06-15&rft.issn=0020-7136&rft.eissn=1097-0215&rft.volume=124&rft.issue=12&rft.spage=2938&rft.epage=2941&rft_id=info:doi/10.1002%2Fijc.24285&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_ijc_24285 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon |